This paper reviews the évidence for the claims of health benefits derived from the use of probiotics. A brief history of probiotics and the types of probiotics currently used and the criteria for the sélection of probiotics is discussed. The ability of probiotics to enhance the nutritional content and bioavailability of nutrients and the scientific évidence for the usefulness of probiotics in alleviating the Symptoms of lactose intolérance and in enhancing growth development is examined. The remainder of the review focuses on studies of a spécifie probiotic, Lactobacillus GG which has been extensively investigated for its health benefits in humans and animais. These studies serve as a model for the potential benefits of probiotics. The ability of Lactobacillus GG to treat or prevent diarrhoeal disease, to serve as an adjuvant for vaccines, to prevent rotavirusinduced diarrhoea, to prevent milk-based allergie reactions, alcohol-induced liver disease and colon cancer are presented. The review concludes with a discussion of the data supporting the safety of probiotics.
For thousands of years microbial cultures hâve been used to ferment foods and prépare alcoholic beverages. In Genesis références are made to the préparation of fermented milk. In the past Century, various différent micro-organisms hâve been tested for their ability to prevent and cure diseases in animais and humans. Micro-organisms hâve also been added to domestic animal feed to enhance growth. Based on thèse new applications, the word probiotic was used to describe bénéficiai micro-organisms by Lilley & Stillwell (1965) . Füller (1992) defined a probiotic as 'a live microbial feed supplément which beneficially affects the host animal by improving its microbial balance'. In this paper a review of probiotics currently used, sélection criteria for probiotics, purported health claims for probiotics and scientific évidence for thèse claims will be presented.
Results and discussion

Sélection criteria for probiotics
One criteria which has been used to sélect probiotics is species compatibility. The gênerai principle is that a probiotic isolated from an animal is less effective in another animal. However, many probiotics are of unknown origin and therefore inter-species use of probiotics is common. The other major sélection criteria that hâve been applied for probiotics include the ability to survive transit through the gastrointestinal tract, adhérence to the intestinal epithelial cell lining, production of antimicrobial substances towards pathogens, ability to stabilize the intestinal microflora, antigenotoxic properties, a short génération time, a good shelf life in food or powdered préparations and non-pathogenic properties. In regard to the ability to survive in the gastrointestinal tract a potential probiotic's ability to survive in a low pH environment and to survive in the présence of bile has been used as a screening technique. Many probiotics currently being used hâve been assumed to be safe based on past history of a lack of médical problems reported for the gênera of which that probiotic is a member. An example has been Lactobacillus and Bifidobacterium. However, there can be species différences in pathogenicity and this is always an issue that should be considered in the sélection of probiotics. Animal feeding studies using reasonable doses can be helpful in this regard. In gênerai, probiotics that hâve been selected in récent years meet at least some of the criteria listed above. In contrast microorganisms that hâve been used for many years in the food industry and as over-the-counter health suppléments often hâve not met any of the expérimental sélection criteria listed above and hence often may not survive in the gastrointestinal tract. Table 1 contains a partial list of probiotics that hâve been used or are currently used for human and animal consumption. The majority of probiotics are bacterial, with the species of Lactobacillus and Bifidobacterium being the most common type of bacteria used (Füller. 1992) .
Probiotics currently in use
The list, although appearing relatively long, is actually only a small fraction of ail of the micro-organisms known that are believed to be non-pathogenic. Therefore, some specificity has been applied in the past for the sélection of probiotics. However, as stated above, the sélection process in various dairy product is shown (Shahani & Chandan, 1979) . Similarly fermentation has been shown to increase niacin in yoghurt, cottage cheese and cheddar cheese and riboflavin in yoghurt (Deeth & Tomine, 1981) . These studies indicate that to a limited extent the action of micro-organisms either during the préparation of cultured foods or in the digestive tract can either improve the digestibility or absolute amounts of some dietary nutrients.
Probiotics and health benefits
There is a long list of health and developmental benefits that hâve been attributed to probiotics (Hitchins & McDonough, 1989) . A partial list of thèse therapeutic and bénéficiai claims for probiotics are listed in Table 3 . In this paper no attempt will be made to discuss ail of thèse claims, rather some évidence will be presented for a bénéficiai rôle for probiotics in the treatment of lactose intolérance and for weight gain in infants and young animais. The remainder of this review will cover the expérimental évidence that has been generated for the bénéficiai properties of a spécifie probiotic in the areas of intestinal infection and intestinal immunity, food allergies and colon cancer.
Lactose intolérance
The disaccharide lactose can cause severe intestinal distress characterized by bloating, flatulence and abdominal pain in individuals with a low level of the intestinal enzyme i8-galactosidase (lactase). This condition severely restricts the use of dairy products. Since the condition tends to become more severe with âge, it limits the consumption of calcium-rich foods when they are critically needed due to bone loss in the elderly. During fermentation, lactobacilli produce lactase which hydrolyses the lactose in dairy products to glucose and galactose. During yoghurt fermentation the production of lactase steadily increases. Kim & Gilliland (1983) found that feeding fermented milk to
Probiotics and nutritional enhancement
Bacterial enzymatic hydrolysis has been shown to enhance the bioavailability of protein and fat (Friend & Shahani, 1984) . Bacterial protease can increase the production of free amino acids which can benefit the nutritional status of the host particularly if the host has a deficiency in endogenous protease production. Lactic acid bacteria hâve also been shown to increase the content of the vitamin B complex in fermented foods.
In Table 2 the effect of fermentation on folie acid content Health benefits of probiotics S205 lactose-intolerant subjects resulted in a significantly lower level of hydrogen in the breath when compared to the hydrogen levels for subjects fed unfermented milk. Hydrogen in the breath is a marker for bacterial metabolism of lactose in the largerbowel. A lower hydrogen level indicates the lactose was metabolized prior to entering the large intestine. Kolars et al. (1984) found that the administration of 18 g of lactose in yoghurt resulted in one-third the amount of hydrogen in the breath compared to a similar dose of lactose delivered in milk. Analyses of duodenal aspirâtes indicated significant lactase activity in the intestine 1 h after the administration of the yoghurt.
Growth during development
A number of probiotics hâve been added to animal feed to increase the weight of domestic animais. The increase in weight gain presumably results from infection control and from increased digestibility of nutrients. Animal feeding studies in young rats (Hargrove & Alford, 1980; Wong etal. 1983 ) fed a liquid diet consisting either of milk, yoghurt or milk fermented with S. thermophilus hâve shown a significantly higher weight gain for the animais on the fermented products. In 4 weeks the animais fed milk gained 116 g v. 136-3 g when fed yoghurt and 131-3 g when maintained on a S. thermophilus fermented milk diet. A similar study has been conducted in humans (Robinson & Thompson, 1952) . Bottle-fed infants during the first month of life gained on average 21-9ozs when fed a standard formula and 26-5 ozs when L. acidophilus was added to the formula.
From a number of différent types of observations évi-dence has emerged that probiotics are bénéficiai in promoting growth in young animais and humans. The mechanism for this enhanced growth has not been definitively proven and remains spéculative and is based on the assumptions stated at the beginning of this section.
Lactobacillus GG
Lactobacillus GG (LGG) is a widely used probiotic which has been investigated in expérimental animal modeis, human expérimental studies, clinical human studies, tissue culture and in vitro (Saxelin, 1997) . This organism has been more widely studied than any other probiotic over the past 10 years and therefore is a good model for reviewing the Potential health benefits of probiotics.
LGG was isolated from a human faecal culture in 1985 (Gorbach, 1996) . The organism has been identified taxonomically by using genetic probes and protein electrophoretic patterns as a L. rhamnosum. The organism, however, is an atypical rhamnosum because it cannot ferment lactose, maitose or sucrose and only ferments rhamnose very slowly.
Diarrhoeal studies
An initial report in five patients (Gorbach et al. 1987) indicated that LGG could stop épisodes of relapsing diarrhoea caused by a Clostridium difficile produced toxin. The LGG also decreased toxin levels in the faeces of these patients. An additional thirty-two patients hâve now been studied for the efficacy of LGG in the treatment of relapsing C. difficile induced diarrhoea (Gorbach, \996b). Of these thirty-two patients 84% were cured by initial treatment with LGG daily for 2 weeks. Of the thirty-two patients three were cured upon retreatment with LGG resulting in an overall eure rate of 94 %.
LGG has been shown to lower the rate of diarrhoea in Finnish people travelling to Turkey (Oksanen et al. 1990) and Americans travelling to developing countries (Hilton et al. 1997) . The study performed with American travellers was a randomized placebo design. The subjects who took the placebo had a 7-4% per day risk of developing diarrhoea. Those travellers who ingested LGG daily had a 3-9 % per day risk of developing diarrhoea. This translated into a 47 % protection rate which was similar to the 39-5 % protection rate noted for Finnish travellers to one site in Turkey.
LGG has also been shown to be effective for the treatment of children hospitalized for severe diarrhoea. Isolauri et al. (1991) reported that during the hospitalization all children were rehydrated and realimented. The children were randomized into two groups. One group reeeived a placebo and the second group was given LGG. The duration of diarrhoea was reduced from 2-5 d for the placebo group to 11 d (P = 0-001) for the group given LGG. The number of intestinal immunoglobin-secreting cells (ISC) in the LGG group was almost twice that in the placebo group for immunoglobulin M (IgM), IgA and IgG isotopes.
These studies demonstrate that a probiotic can be effective in treating antibiotic-induced diarrhoea in adults, diarrhoeal disease acquired during travel (which most likely has a mixed bacterial and viral aetiology) and diarrhoeal disease in young children predominantly caused by rotaviruses. Diarrhoea Worldwide is a major incapacitating disease in adults and a major cause of death in infants in developing countries. Therefore, the use of probiotics may be an important tool in improving health and nutrition in many developing countries.
Vaccine adjuvant
In conjunetion with studies that indicated LGG increased intestinal immunity in children with rotavirus-induced diarrhoea, Isolauri et al. (1995) tested LGG as an adjuvant to an oral vaccine to rotavirus in children. There was an increase of rotavirus-speeifie IgM-secreting cells in the LGG group compared to placebo 8d postvaccination.
LGG also increased IgA and IgM seroconversion when measured in paired sera measured prior to vaccination and 30 d postvaccination.
Food allergy
The milk protein casein is responsible for the first allergie reactions in milk-fed infants.
LGG and other lactobacilli can dégrade milk proteins to smaller peptides and amino aeids (Sutas et al. 1996) . LGG hydrolysis of various différent casein proteins decreased the prolifération of mitogeninduced human lymphocytes compared to the non-treated caseins (Sutas et al. 1996) . Therefore, the effect of LGG supplementation for infants with atopic eczéma was studied. The study was performed at the same time that cow milk was eliminated from the diet (Majamaa & Isolauri, 1997) . Thirty-one infants were divided into a placebo group (n -16) who were fed a hydrolysed whey formula and a study group (n = 15) who were fed the same formula with LGG added. After 1 month the clinical Symptoms alone decreased significantly for the children given LGG (P = 0004) but not for the placebo group. The major improvement in the study group was due to a réduction in the extent and intensity of atopic dermatitis. These results suggest that probiotics may downregulate intestinal inflammation and hypersensitivity reactions in infants with food allergies and resulting atopic eczéma.
hiver disease
Alcohol-induced liver disease has been shown to correlate with plasma levels of bacterial endotoxin. Nanji et al. (1994) studied the effect of LGG on the level of plasma endotoxin and liver pathology in rats chronically fed alcohol. The concentration of plasma endotoxin was significantly reduced in the group of animais fed LGG. The mean value in the control group was 48-3 pg/ml and in the group given LGG the plasma endotoxin level was 8-4 pg/ml. There was also a significantly lower (P< 001) liver pathology score in the LGG-fed group. These results indicate that probiotics may be useful in preventing alcohol-induced liver damage, a common condition in many societies.
Colon cancer
A dimethylhydrazine (DMH) induced colon cancer model was used in our laboratory (Goldin et al. 1996) to détermine if LGG could protect against the formation of colon tumours. If LGG was introduced into the feed 3 weeks prior to initiating a 16-week course of DMH injections (weekly) there was a significant réduction in the incidence of colon tumours (P -0-012) and in the number of tumours per tumour-bearing animal (P < 002) when compared to animais that were administered DMH but did not receive the LGG supplementation. The magnitude of the tumour réduction was similar to that seen in this model when the dietary fat is drastically reduced. These data suggest probiotics if taken on a regulär basis may lower the incidence of colon tumours. However, confirmation of this hypothesis is difficult to obtain in the human population.
Safety of probiotics
Most probiotics hâve been designated as "generally recognized as safe' (GRAS) based on their long history of use in food fermentation. However, there hâve been occasional reports of bacteraemias and endocarditis associated with Lactobacillus generally in severely immunocompromised individuals. This prompted the suggestion that some type of surveillance be instituted for probiotics. Salminen & Donahue (1996) reviewed the safety data and found no évidence of probiotics being involved in human infections. This is supported by epidemiological data on the safety of dairy products (Salminen & Donahue, 1996; Saxelin, 1997) . Blood cultures isolated from bacteraemia patients in southern Finland were studied. A total of 5192 blood culture isolâtes were recovered from patients with bacteraemia. Twelve isolâtes contained lactobacilli. None of thèse lactobacilli corresponded to LGG or any other Lactobacillus used in dairy products or pharmaceutical préparations. These data strongly support the fact that Lactobacillus is rarely found in bacteraemial infections and that the current probiotics lack a pathogenic potential. Negative results do not totally rule out the possibility that current or future probiotics can cause infection; however, to date the probiotics currently being used appear to be safe.
Conclusion
This review article has presented data showing that probiotics hâve significant potential in improving human health and preventing and treating disease. Future research is required to further delineate this potential and to develop new and improved probiotics. 
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